Cetera Trust Company N.A Raises Holdings in CVS Health Corporation $CVS

Cetera Trust Company N.A increased its position in CVS Health Corporation (NYSE:CVS) by 6.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,268 shares of the pharmacy operator’s stock after buying an additional 725 shares during the quarter. Cetera Trust Company N.A’s holdings in CVS Health were worth $846,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in CVS. Avion Wealth raised its position in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. purchased a new position in CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc raised its position in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC raised its position in CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the period. Finally, ORG Partners LLC raised its position in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CVS shares. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and raised their target price for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Cowen restated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Barclays raised their target price on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Jefferies Financial Group raised their target price on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Finally, TD Cowen lifted their price target on CVS Health from $99.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.82.

CVS Health Stock Performance

Shares of CVS stock opened at $78.71 on Thursday. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The business has a 50 day moving average of $76.90 and a two-hundred day moving average of $69.27. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15. The company has a market cap of $99.92 billion, a P/E ratio of 207.14, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the firm posted $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is 700.00%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.22% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.